The Neurodegeneration Consortium

A transformational initiative to identify and develop novel
therapeutics for Alzheimer’s disease

Innovation Through Collaboration

News & Insights

  • 2012
  • Oct
The Robert A. and Renee E. Belfer Family Foundation commits to philanthropic donation of $25 million to form the Neurodegeneration Consortium (NDC).

The multi-disciplinary team will include researchers from Baylor College of Medicine, the Massachusetts Institute of Technology and the University of Texas MD Andersons Cancer Center’s Institute for Applied Cancer Science (IACS).

The aim is to better understand the underlying biology of Alzheimer’s disease and translate this knowledge into therapeutic interventions that can effectively alleviate symptoms by delaying, reversing and/or eliminating the pathology of the disease.

The gift is contingent on consortium partners raising an additional $25 million by January 2016.

  • 2013
  • Aug
The Neurodegeneration Consortium receives $5 million toward matching commitment from the Huffington Foundation.
  • 2015
  • Aug
The Neurodegeneration Consortium receives $3 million from the Chapman Foundation.
  • 2015
  • Dec
Axxam SpA (Milan/Italy) and the Neurodegeneration Consortium (NDC) at the University of Texas MD Anderson Cancer Center collaborate on a novel approach to Alzheimer’s disease research

The aim of the collaboration is to identify and develop novel small molecule modulators of an undisclosed G-protein coupled receptor linked to Alzheimer’s disease.